Profound Medical (PROF) Revenue & Revenue Breakdown
Profound Medical Revenue Highlights
Latest Revenue (Y)
$16.10M
Latest Revenue (Q)
$2.48M
Main Segment (Y)
Recurring - Non-Capital
Main Geography (Y)
UNITED STATES
Profound Medical Revenue by Period
Profound Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $16.10M | 58.33% |
| 2024-12-31 | $10.17M | 41.23% |
| 2023-12-31 | $7.20M | 7.75% |
| 2022-12-31 | $6.68M | -2.79% |
| 2021-12-31 | $6.87M | -5.90% |
| 2020-12-31 | $7.30M | 74.99% |
| 2019-12-31 | $4.17M | 118.47% |
| 2018-12-31 | $1.91M | -51.01% |
| 2017-12-31 | $3.90M | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | - |
Profound Medical generated $16.10M in revenue during NA 2025, up 58.33% compared to the previous quarter, and up 220.40% compared to the same period a year ago.
Profound Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $2.48M | -52.82% |
| 2026-03-31 | $5.26M | -11.94% |
| 2025-12-31 | $5.98M | 13.01% |
| 2025-09-30 | $5.29M | 139.21% |
| 2025-06-30 | $2.21M | -15.64% |
| 2025-03-31 | $2.62M | -35.43% |
| 2024-12-31 | $4.06M | 43.33% |
| 2024-09-30 | $2.83M | 26.85% |
| 2024-06-30 | $2.23M | 55.15% |
| 2024-03-31 | $1.44M | -45.94% |
| 2023-12-31 | $2.66M | 54.04% |
| 2023-09-30 | $1.73M | 7.87% |
| 2023-06-30 | $1.60M | -13.88% |
| 2023-03-31 | $1.86M | 9.30% |
| 2022-12-31 | $1.70M | -39.45% |
| 2022-09-30 | $2.81M | 39.99% |
| 2022-06-30 | $2.01M | 17.74% |
| 2022-03-31 | $1.71M | 35.13% |
| 2021-12-31 | $1.26M | -60.73% |
| 2021-09-30 | $3.21M | 23.39% |
| 2021-06-30 | $2.60M | 191.49% |
| 2021-03-31 | $893.60K | -75.62% |
| 2020-12-31 | $3.66M | 63.74% |
| 2020-09-30 | $2.24M | 118.13% |
| 2020-06-30 | $1.03M | -11.55% |
| 2020-03-31 | $1.16M | -46.49% |
| 2019-12-31 | $2.17M | 217.74% |
| 2019-09-30 | $682.22K | 56.00% |
| 2019-06-30 | $437.32K | -60.43% |
| 2019-03-31 | $1.11M | -9.34% |
| 2018-12-31 | $1.22M | 418.72% |
| 2018-09-30 | $235.03K | 44.89% |
| 2018-06-30 | $162.21K | -44.34% |
| 2018-03-31 | $291.41K | -80.18% |
| 2017-12-31 | $1.47M | 24.49% |
| 2017-09-30 | $1.18M | 60.51% |
| 2017-06-30 | $735.94K | 65.92% |
| 2017-03-31 | $443.56K | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-03-31 | - | - |
Profound Medical generated $2.48M in revenue during Q2 2026, up -52.82% compared to the previous quarter, and up 94.73% compared to the same period a year ago.
Profound Medical Revenue Breakdown
Profound Medical Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|
| Capital Equipment | $6.37M | $2.44M | - | - |
| Recurring - Non-Capital | $9.73M | $8.24M | - | - |
| Capital equipment | - | - | $2.00M | $3.15M |
| Recurring - non-capital | - | - | $4.68M | $3.29M |
Profound Medical's latest annual revenue breakdown by segment (product or service), as of Dec 25: Recurring - Non-Capital (60.44%), and Capital Equipment (39.56%).
Quarterly Revenue by Product
| Product/Service | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 |
|---|---|---|---|---|---|---|
| Capital Equipment | $871.00K | $2.86M | $3.67M | $1.22M | $650.00K | $820.00K |
| Recurring - Non-Capital | $1.61M | $2.47M | $2.30M | $4.07M | $1.56M | $1.80M |
Profound Medical's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Recurring - Non-Capital (64.92%), and Capital Equipment (35.08%).
Profound Medical Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 | Dec 24 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| UNITED STATES | $12.24M | $7.35M | - | - | - |
| GERMANY | $773.00K | - | - | - | - |
| CANADA | $3.08M | - | - | - | - |
| CALIFORNIA | - | $2.44M | - | - | - |
| DELAWARE | - | $891.00K | - | - | - |
| USA | - | - | $3.40M | $2.09M | - |
| Canada | - | - | $1.49M | $1.72M | - |
| Germany | - | - | $1.80M | $1.43M | - |
| C | - | - | - | - | $4.76M |
| D | - | - | - | - | $1.47M |
Profound Medical's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (76.07%), CANADA (19.13%), and GERMANY (4.80%).
Quarterly Revenue by Country
| Country | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 |
|---|---|---|---|---|---|---|
| UNITED STATES | $1.75M | $1.62M | $3.72M | $5.00M | $1.98M | $1.54M |
| GERMANY | $182.00K | $150.00K | $465.00K | $168.00K | $140.00K | - |
| CANADA | $556.00K | $3.57M | $1.94M | $570.00K | $570.00K | - |
| CALIFORNIA | - | - | - | - | - | $852.00K |
| DELAWARE | - | - | - | - | - | $226.00K |
Profound Medical's latest quarterly revenue breakdown by geography, as of Jun 26: UNITED STATES (70.28%), CANADA (22.39%), and GERMANY (7.33%).
Profound Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| STIM | Neuronetics | $149.16M | $41.57M |
| OWLT | Owlet | $105.70M | $22.50M |
| LNSR | LENSAR | $58.44M | $16.50M |
| TLSI | TriSalus Life Sciences | $45.15M | $11.41M |
| MXCT | MaxCyte | $33.03M | $7.27M |
| PRE | Prenetics Global | $21.74M | $6.41M |
| PROF | Profound Medical | $16.10M | $2.48M |
| NNOX | Nano-X Imaging | $9.90M | $2.55M |
| AVR | Anteris Technologies Global | $1.91M | $1.01M |
| CATX | Perspective Therapeutics | - | $-76.00K |